GH Research (FRA:1KA) Other Income (Expense) : €0.35 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is GH Research Other Income (Expense)?

GH Research's other income expense for the GH Research's pretax income for the three months ended in Mar. 2024 was €1.22 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was €0.35 Mil.

GH Research Other Income (Expense) Historical Data

The historical data trend for GH Research's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GH Research Other Income (Expense) Chart

GH Research Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Other Income (Expense)

5.23

6.77

-2.40

GH Research Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Income (Expense)	Get a 7-Day Free Trial													-1.53	0.03	1.72	-2.62	1.22

GH Research Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.35 Mil.

GH Research (FRA:1KA) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

GH Research (FRA:1KA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (FRA:1KA) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

GHRS:USA

Address

28 Baggot Street Lower, Dublin, IRL, D02 NX43

Website

https://www.ghres.com

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. Its focus is on developing novel and proprietary 5-Methoxy-N,N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.

GH Research (FRA:1KA) Headlines

No Headlines